BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

745 related articles for article (PubMed ID: 33604698)

  • 1. Multi-omics highlights ABO plasma protein as a causal risk factor for COVID-19.
    Hernández Cordero AI; Li X; Milne S; Yang CX; Bossé Y; Joubert P; Timens W; van den Berge M; Nickle D; Hao K; Sin DD
    Hum Genet; 2021 Jun; 140(6):969-979. PubMed ID: 33604698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mendelian randomization analysis identifies druggable genes and drugs repurposing for chronic obstructive pulmonary disease.
    Wang Z; Li S; Cai G; Gao Y; Yang H; Li Y; Liang J; Zhang S; Hu J; Zheng J
    Front Cell Infect Microbiol; 2024; 14():1386506. PubMed ID: 38660492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-ancestry Mendelian randomization of omics traits revealing drug targets of COVID-19 severity.
    Zheng J; Zhang Y; Zhao H; Liu Y; Baird D; Karim MA; Ghoussaini M; Schwartzentruber J; Dunham I; Elsworth B; Roberts K; Compton H; Miller-Molloy F; Liu X; Wang L; Zhang H; Smith GD; Gaunt TR
    EBioMedicine; 2022 Jul; 81():104112. PubMed ID: 35772218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance.
    Anisul M; Shilts J; Schwartzentruber J; Hayhurst J; Buniello A; Shaikho Elhaj Mohammed E; Zheng J; Holmes M; Ochoa D; Carmona M; Maranville J; Gaunt TR; Emilsson V; Gudnason V; McDonagh EM; Wright GJ; Ghoussaini M; Dunham I
    Elife; 2021 Aug; 10():. PubMed ID: 34402426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leveraging lung tissue transcriptome to uncover candidate causal genes in COPD genetic associations.
    Lamontagne M; Bérubé JC; Obeidat M; Cho MH; Hobbs BD; Sakornsakolpat P; de Jong K; Boezen HM; ; Nickle D; Hao K; Timens W; van den Berge M; Joubert P; Laviolette M; Sin DD; Paré PD; Bossé Y
    Hum Mol Genet; 2018 May; 27(10):1819-1829. PubMed ID: 29547942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic mechanisms of COVID-19 and its association with smoking and alcohol consumption.
    Rao S; Baranova A; Cao H; Chen J; Zhang X; Zhang F
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34308962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 and Thyroid Function: A Bi-Directional Two-Sample Mendelian Randomization Study.
    Li GH; Tang CM; Cheung CL
    Thyroid; 2022 Sep; 32(9):1037-1050. PubMed ID: 35734897
    [No Abstract]   [Full Text] [Related]  

  • 8. An Integrative Genomic Strategy Identifies sRAGE as a Causal and Protective Biomarker of Lung Function.
    Keefe J; Yao C; Hwang SJ; Courchesne P; Lee GY; Dupuis J; Mizgerd JP; O'Connor G; Washko GR; Cho MH; Silverman EK; Levy D
    Chest; 2022 Jan; 161(1):76-84. PubMed ID: 34237330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress gene expression, DNA methylation, and gut microbiota interaction trigger Crohn's disease: a multi-omics Mendelian randomization study.
    Xu S; Li X; Zhang S; Qi C; Zhang Z; Ma R; Xiang L; Chen L; Zhu Y; Tang C; Bourgonje AR; Li M; He Y; Zeng Z; Hu S; Feng R; Chen M
    BMC Med; 2023 May; 21(1):179. PubMed ID: 37170220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic Association vs. Serological Determination of ABO Blood Types in a Chinese Cohort, with Application in Mendelian Randomization.
    Wang M; Gao J; Liu J; Zhao X; Lei Y
    Genes (Basel); 2021 Jun; 12(7):. PubMed ID: 34202464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRLocus: Identifying causal genes mediating a trait through Bayesian estimation of allelic heterogeneity.
    Zhu A; Matoba N; Wilson EP; Tapia AL; Li Y; Ibrahim JG; Stein JL; Love MI
    PLoS Genet; 2021 Apr; 17(4):e1009455. PubMed ID: 33872308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues.
    D'Antonio M; Nguyen JP; Arthur TD; Matsui H; ; D'Antonio-Chronowska A; Frazer KA
    Cell Rep; 2021 Nov; 37(7):110020. PubMed ID: 34762851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating causal effects of atherogenic lipid-related traits on COVID-19 susceptibility and severity using a two-sample Mendelian randomization approach.
    Yoshikawa M; Asaba K; Nakayama T
    BMC Med Genomics; 2021 Nov; 14(1):269. PubMed ID: 34774031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Drug Targets for Ischemic Stroke Identified Through Mendelian Randomization Analysis of the Blood Proteome.
    Chong M; Sjaarda J; Pigeyre M; Mohammadi-Shemirani P; Lali R; Shoamanesh A; Gerstein HC; Paré G
    Circulation; 2019 Sep; 140(10):819-830. PubMed ID: 31208196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prioritizing putative influential genes in cardiovascular disease susceptibility by applying tissue-specific Mendelian randomization.
    Taylor K; Davey Smith G; Relton CL; Gaunt TR; Richardson TG
    Genome Med; 2019 Jan; 11(1):6. PubMed ID: 30704512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma.
    Zhang L; Xiong Y; Zhang J; Feng Y; Xu A
    J Transl Med; 2024 Apr; 22(1):330. PubMed ID: 38576019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes.
    Yang C; Fagan AM; Perrin RJ; Rhinn H; Harari O; Cruchaga C
    Genome Med; 2022 Dec; 14(1):140. PubMed ID: 36510323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19.
    Gaziano L; Giambartolomei C; Pereira AC; Gaulton A; Posner DC; Swanson SA; Ho YL; Iyengar SK; Kosik NM; Vujkovic M; Gagnon DR; Bento AP; Barrio-Hernandez I; Rönnblom L; Hagberg N; Lundtoft C; Langenberg C; Pietzner M; Valentine D; Gustincich S; Tartaglia GG; Allara E; Surendran P; Burgess S; Zhao JH; Peters JE; Prins BP; Angelantonio ED; Devineni P; Shi Y; Lynch KE; DuVall SL; Garcon H; Thomann LO; Zhou JJ; Gorman BR; Huffman JE; O'Donnell CJ; Tsao PS; Beckham JC; Pyarajan S; Muralidhar S; Huang GD; Ramoni R; Beltrao P; Danesh J; Hung AM; Chang KM; Sun YV; Joseph J; Leach AR; Edwards TL; Cho K; Gaziano JM; Butterworth AS; Casas JP;
    Nat Med; 2021 Apr; 27(4):668-676. PubMed ID: 33837377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD.
    Sun W; Kechris K; Jacobson S; Drummond MB; Hawkins GA; Yang J; Chen TH; Quibrera PM; Anderson W; Barr RG; Basta PV; Bleecker ER; Beaty T; Casaburi R; Castaldi P; Cho MH; Comellas A; Crapo JD; Criner G; Demeo D; Christenson SA; Couper DJ; Curtis JL; Doerschuk CM; Freeman CM; Gouskova NA; Han MK; Hanania NA; Hansel NN; Hersh CP; Hoffman EA; Kaner RJ; Kanner RE; Kleerup EC; Lutz S; Martinez FJ; Meyers DA; Peters SP; Regan EA; Rennard SI; Scholand MB; Silverman EK; Woodruff PG; O'Neal WK; Bowler RP; ;
    PLoS Genet; 2016 Aug; 12(8):e1006011. PubMed ID: 27532455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of body composition on COVID-19 susceptibility and severity: A two-sample multivariable Mendelian randomization study.
    Freuer D; Linseisen J; Meisinger C
    Metabolism; 2021 May; 118():154732. PubMed ID: 33631142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.